Sex differences in effort-related decision-making: role of dopamine D2 receptor antagonism

被引：0
作者：
Emily L. Errante
Marilyn Chakkalamuri
Oreoluwa I. Akinbo
Samantha E. Yohn
John D. Salamone
Leslie Matuszewich
机构：
[1] Northern Illinois University,Division of Neuroscience and Behavior, Department of Psychology
[2] Midwestern University,Chicago College of Osteopathic Medicine
[3] University of Connecticut,Department of Psychology
来源：
Psychopharmacology | 2021年 / 238卷
关键词：
Motivation; Reward; Depression; Sex differences; Dopamine; D2 receptor; Food restriction; Behavioral activation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1609 / 1619
页数：10
相关论文
共 50 条
  • [31] The role of ‘jackpot’ stimuli in maladaptive decision-making: dissociable effects of D1/D2 receptor agonists and antagonists
    Aaron P. Smith
    Rebecca S. Hofford
    Thomas R. Zentall
    Joshua S. Beckmann
    Psychopharmacology, 2018, 235 : 1427 - 1437
  • [32] Decomposing risky decision-making in methamphetamine use disorder: Behavioral updating and D2 dopamine receptors
    Guttman, Zoe
    Mandelkern, Mark
    Ghahremani, Dara G.
    Kohno, Milky
    Dean, Andy C.
    London, Edythe D.
    DRUG AND ALCOHOL DEPENDENCE, 2023, 246
  • [33] Facial mimicry is not modulated by dopamine D2/3 and opioid receptor antagonism
    Sebastian Korb
    Alasdair Clarke
    Claudia Massaccesi
    Matthäus Willeit
    Giorgia Silani
    Psychopharmacology, 2023, 240 : 2081 - 2091
  • [34] The VMAT-2 inhibitor tetrabenazine alters effort-related decision making as measured by the T-maze barrier choice task: reversal with the adenosine A2A antagonist MSX-3 and the catecholamine uptake blocker bupropion
    Samantha E. Yohn
    Christian Thompson
    Patrick A. Randall
    Christie A. Lee
    Christa E. Müller
    Younis Baqi
    Mercè Correa
    John D. Salamone
    Psychopharmacology, 2015, 232 : 1313 - 1323
  • [35] The VMAT-2 inhibitor tetrabenazine alters effort-related decision making as measured by the T-maze barrier choice task: reversal with the adenosine A2A antagonist MSX-3 and the catecholamine uptake blocker bupropion
    Yohn, Samantha E.
    Thompson, Christian
    Randall, Patrick A.
    Lee, Christie A.
    Muller, Christa E.
    Baqi, Younis
    Correa, Merce
    Salamone, John D.
    PSYCHOPHARMACOLOGY, 2015, 232 (07) : 1313 - 1323
  • [36] Dopamine D1 and D2 receptor antagonism effects on rat ultrasonic vocalizations
    Ringel, Lauren E.
    Basken, Jaime N.
    Grant, Laura M.
    Ciucci, Michelle R.
    BEHAVIOURAL BRAIN RESEARCH, 2013, 252 : 252 - 259
  • [37] The adenosine A2A antagonist MSX-3 reverses the effects of the dopamine antagonist haloperidol on effort-related decision making in a T-maze cost/benefit procedure
    Allison M. Mott
    Eric J. Nunes
    Lyndsey E. Collins
    Russell G. Port
    Kelly S. Sink
    Jörg Hockemeyer
    Christa E. Müller
    John D. Salamone
    Psychopharmacology, 2009, 204
  • [38] Dopamine D2/3 receptor antagonism reduces activity-based anorexia
    Klenotich, S. J.
    Ho, E. V.
    McMurray, M. S.
    Server, C. H.
    Dulawa, S. C.
    TRANSLATIONAL PSYCHIATRY, 2015, 5 : e613 - e613
  • [39] Role of Dopamine and D2 Dopamine Receptor in the Pathogenesis of Inflammatory Bowel Disease
    Ganna Tolstanova
    Xiaoming Deng
    Amrita Ahluwalia
    Brankica Paunovic
    Alona Prysiazhniuk
    Lyudmyla Ostapchenko
    Andrzej Tarnawski
    Zsuzsanna Sandor
    Sandor Szabo
    Digestive Diseases and Sciences, 2015, 60 : 2963 - 2975
  • [40] The adenosine A2A antagonist MSX-3 reverses the effects of the dopamine antagonist haloperidol on effort-related decision making in a T-maze cost/benefit procedure
    Mott, Allison M.
    Nunes, Eric J.
    Collins, Lyndsey E.
    Port, Russell G.
    Sink, Kelly S.
    Hockemeyer, Joerg
    Mueller, Christa E.
    Salamone, John D.
    PSYCHOPHARMACOLOGY, 2009, 204 (01) : 103 - 112
12345